# Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC.

> **NCT01291017** · PHASE2 · COMPLETED · sponsor: **University of Florida** · enrollment: 19 (actual)

## Conditions studied

- Non-small Cell Lung Cancer

## Interventions

- **DRUG:** PD0332991

## Key facts

- **NCT ID:** NCT01291017
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2014-02
- **Final completion:** 2015-02
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2016-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01291017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01291017, "Cyclin Dependent Kinase (CDK)4/6 Inhibitor, PD0332991 in Advanced Non-small Cell Lung Cancer NSCLC.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01291017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*